US aims to quicken approvals for cheaper versions of complex drugs

The US Food and Drug Administration said Wednesday it would ease the approvals process for developing replicas of biologic drugs used to treat conditions including autoimmune diseases, cancer and diabetes.
đ Full Story

The Usual Suspects STRIKES AGAIN!
- Truck full of 'aggressive' research monkeys crashes, setting primates on the loose
- Wednesday's Final Word
- How dual smokers of pot and tobacco feel the burn of higher prices
- Zelenskyâs Top Man Is a Big Problem - Andrew Day
- Bruce Willis's Best 90s Movie Is Even Better Than You Remember - Chris Snellgrove
- MiniMax-M2 is the new king of open source LLMs (especially for agentic tool calling) - carl.franzen@venturebeat.com (Carl Franzen)

Forget Flagships, Better Budget Smartphone Deals!
- Colin Farrell Recalls âMinority Reportâ Scene That Took 46 Takes While Drunk, Tom Cruise âWasnât Very Happyâ - Glenn Garner
- Microsoft Copilot gets 12 big updates for fall, including new AI assistant character Mico - carl.franzen@venturebeat.com (Carl Franzen)
- Unlocking Secrets from the Dawn of the Solar System: A Look at Bennu Asteroid's 4.6bn-year-old Dark Dust - Arya Chandran
- DIY Holiday Gifts Might Save You Less Money Than You Think
- One of our favorite Anker MagSafe power banks is 37 percent off right now - Lawrence Bonk
- Huge iguana hit with trespassing, disorderly conduct charges after wrestling with law

